111 related articles for article (PubMed ID: 11211195)
1. A randomized and prospective study comparing treatment with high-dose intravenous immunoglobulin with monoclonal antibodies for rescue of kidney grafts with steroid-resistant rejection.
Casadei DH; del C Rial M; Opelz G; Golberg JC; Argento JA; Greco G; Guardia OE; Haas E; Raimondi EH
Transplantation; 2001 Jan; 71(1):53-8. PubMed ID: 11211195
[TBL] [Abstract][Full Text] [Related]
2. Reversal of steroid- and anti-lymphocyte antibody-resistant rejection using intravenous immunoglobulin (IVIG) in renal transplant recipients.
Luke PP; Scantlebury VP; Jordan ML; Vivas CA; Hakala TR; Jain A; Somani A; Fedorek S; Randhawa P; Shapiro R
Transplantation; 2001 Aug; 72(3):419-22. PubMed ID: 11502969
[TBL] [Abstract][Full Text] [Related]
3. Individualized T cell monitored administration of ATG versus OKT3 in steroid-resistant kidney graft rejection.
Midtvedt K; Fauchald P; Lien B; Hartmann A; Albrechtsen D; Bjerkely BL; Leivestad T; Brekke IB
Clin Transplant; 2003 Feb; 17(1):69-74. PubMed ID: 12588325
[TBL] [Abstract][Full Text] [Related]
4. Half dose of OKT3 is efficient in treatment of steroid-resistant renal allograft rejection.
Midtvedt K; Tafjord AB; Hartmann A; Eide TC; Holdaas H; Nordal KP; Draganov B; Sødal G; Leivestad T; Fauchald P
Transplantation; 1996 Jul; 62(1):38-42. PubMed ID: 8693541
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
6. Preliminary results from a randomized and prospective study of high-dose immunoglobulin versus monoclonal antibody in the rescue of steroid-resistant rejections.
Casadei D; Rial M; Argento J; Goldberg J; Raimondi E
Transplant Proc; 1998 Aug; 30(5):2164. PubMed ID: 9723428
[No Abstract] [Full Text] [Related]
7. OKT3 rescue for steroid-resistant rejection in adult liver transplantation.
Solomon H; Gonwa TA; Mor E; Holman MJ; Gibbs J; Watemberg I; Netto G; Goldstein RM; Husberg BS; Klintmalm GB
Transplantation; 1993 Jan; 55(1):87-91. PubMed ID: 8420070
[TBL] [Abstract][Full Text] [Related]
8. Predicting factors of long-term results of OKT3 therapy for steroid resistant acute rejection following cadaveric renal transplantation.
Rostaing L; Chabannier MH; Modesto A; Rouzaud A; Cisterne JM; Tkaczuk J; Durand D
Am J Nephrol; 1999; 19(6):634-40. PubMed ID: 10592356
[TBL] [Abstract][Full Text] [Related]
9. Comparison of four different immunosuppression protocols without long-term steroid therapy in kidney recipients monitored by surveillance biopsy: five-year outcomes.
Anil Kumar MS; Irfan Saeed M; Ranganna K; Malat G; Sustento-Reodica N; Kumar AM; Meyers WC
Transpl Immunol; 2008 Nov; 20(1-2):32-42. PubMed ID: 18773960
[TBL] [Abstract][Full Text] [Related]
10. Correlation of clinical outcomes after tacrolimus conversion for resistant kidney rejection or cyclosporine toxicity with pathologic staging by the Banff criteria.
Morrissey PE; Gohh R; Shaffer D; Crosson A; Madras PN; Sahyoun AI; Monaco AP
Transplantation; 1997 Mar; 63(6):845-8. PubMed ID: 9089224
[TBL] [Abstract][Full Text] [Related]
11. A randomized prospective trial of low-dose OKT3 induction therapy to prevent rejection and minimize side effects in recipients of kidney transplants.
Flechner SM; Goldfarb DA; Fairchild R; Modlin CS; Fisher R; Mastroianni B; Boparai N; O'Malley KJ; Cook DJ; Novick AC
Transplantation; 2000 Jun; 69(11):2374-81. PubMed ID: 10868643
[TBL] [Abstract][Full Text] [Related]
12. Comparison between bortezomib and rituximab in the treatment of antibody-mediated renal allograft rejection.
Waiser J; Budde K; Schütz M; Liefeldt L; Rudolph B; Schönemann C; Neumayer HH; Lachmann N
Nephrol Dial Transplant; 2012 Mar; 27(3):1246-51. PubMed ID: 21852274
[TBL] [Abstract][Full Text] [Related]
13. Tacrolimus rescue therapy for corticosteroid-resistant and polyclonal antibody-resistant kidney allograft rejections.
Naderi GH; Mehraban D; Ganji MR; Yahyazadeh SR; Latif AH
Urol J; 2009; 6(1):31-4. PubMed ID: 19241339
[TBL] [Abstract][Full Text] [Related]
14. Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation.
Vo AA; Peng A; Toyoda M; Kahwaji J; Cao K; Lai CH; Reinsmoen NL; Villicana R; Jordan SC
Transplantation; 2010 May; 89(9):1095-102. PubMed ID: 20110854
[TBL] [Abstract][Full Text] [Related]
15. OKT3 therapy in addition to tacrolimus is associated with improved long-term function in patients with steroid refractory renal allograft rejection.
Patschan D; Kribben A; Pietruck F; Lutz J; Binek M; Philipp T; Heemann U; Witzke O
Nephron Clin Pract; 2006; 103(3):c94-9. PubMed ID: 16534238
[TBL] [Abstract][Full Text] [Related]
16. Treatment of simultaneous acute antibody-mediated rejection and acute cellular rejection with alemtuzumab in kidney transplantation: a case report.
Jirasiritham S; Khunprakant R; Techawathanawanna N; Jirasiritham S; Mavichak V
Transplant Proc; 2010 Apr; 42(3):987-9. PubMed ID: 20430222
[TBL] [Abstract][Full Text] [Related]
17. Use of high-dose human immune globulin in highly sensitized patients on the kidney transplant waiting list: one center's experience.
Gozdowska J; Urbanowicz A; Perkowska-Ptasinska A; Michalska K; Chmura A; Szmidt J; Durlik M
Transplant Proc; 2009 Oct; 41(8):2997-3001. PubMed ID: 19857660
[TBL] [Abstract][Full Text] [Related]
18. OKT3 treatment for steroid-resistant acute rejection in kidney transplantation.
Sevmis S; Emiroglu R; Karakayali F; Yagmurdur MC; Dalgic A; Moray G; Haberal M
Transplant Proc; 2005 Sep; 37(7):3016-8. PubMed ID: 16213290
[TBL] [Abstract][Full Text] [Related]
19. Long-term results of ABO-incompatible living kidney transplantation: a single-center experience.
Tanabe K; Takahashi K; Sonda K; Tokumoto T; Ishikawa N; Kawai T; Fuchinoue S; Oshima T; Yagisawa T; Nakazawa H; Goya N; Koga S; Kawaguchi H; Ito K; Toma H; Agishi T; Ota K
Transplantation; 1998 Jan; 65(2):224-8. PubMed ID: 9458019
[TBL] [Abstract][Full Text] [Related]
20. A Scandinavian two-center study of BMA 031 in steroid-resistant rejection of renal grafts.
Pfeffer PF; Ohlman S; Jakobsen A; Fauchald P; Leivestad T; Tydén G; Flatmark A
Transplantation; 1993 Aug; 56(2):304-7. PubMed ID: 8102820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
